CD4 and COVID-19: SARS-CoV-2 spike (S) protein reactive T-cells were identified in immunocompetent (IC) patients suffering from moderate, severe, and critical COVID-19 [8], and a dominance of CD4+ T-cell over CD8+ T-cell response was observed in severe and mild COVID-19 patients [9].